TABLE 2.
Overview of adjunctive treatment for thrombocytopenia for the HC and EACA groups.
Immunosuppressants | HC group, N (%) | EACA group, N (%) |
---|---|---|
GC* only | 6 (18.2) | 8 (36.4) |
GC + azathioprine | 10 (30.3) | 4 (18.2) |
GC + cyclosporine | 5 (15.2) | 4 (18.2) |
GC + mycophenolate | 8 (24.2) | 5 (22.7) |
GC + 2 second agents | 3 (9.1) | 1 (4.5) |
No immunosuppressants | 1 (3) | 0 |
IVIG or vincristine | HC group, N (%) | EACA group, N (%) |
---|---|---|
Vincristine | 20 (60.6) | 15 (68.2 |
IVIG | 3 (9.1) | 0 |
IVIG + vincristine | 6 (18.2) | 0 |
No IVIG or vincristine | 4 (12.1) | 7 (31.8) |
Abbreviation: GC*, glucocorticoid.